Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Clinical data of the REVERSE trial reveals how CRT improves functioning of the heart

Clinical data of the REVERSE trial reveals how CRT improves functioning of the heart

Boston Scientific to discuss final results of MADIT-CRT trial at the European Society of Cardiology Congress

Boston Scientific to discuss final results of MADIT-CRT trial at the European Society of Cardiology Congress

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

CardioMEMS raises $22.1M to fund clinical trial of its heart failure pressure measurement system

CardioMEMS raises $22.1M to fund clinical trial of its heart failure pressure measurement system

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

The Society of Chest Pain Centers announces a new grant program to encourage clinical research

The Society of Chest Pain Centers announces a new grant program to encourage clinical research

Women face higher risk of mortality rate following acute coronary syndromes

Women face higher risk of mortality rate following acute coronary syndromes

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

CardioDx completes multicenter validation study for Corus CAD

CardioDx completes multicenter validation study for Corus CAD

Patients suffering from functional and degenerative mitral regurgitation treated using the MitraClip system

Patients suffering from functional and degenerative mitral regurgitation treated using the MitraClip system

Cell Therapeutics' NDA for Pixantrone accepted by the FDA

Cell Therapeutics' NDA for Pixantrone accepted by the FDA

MedAssurant announces certification of event rate outcomes for HIP Medicare Advantage patients

MedAssurant announces certification of event rate outcomes for HIP Medicare Advantage patients

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

FDA permits Worldheart for bridge-to-transplant study of the Levacor Ventricular Assist Device

FDA permits Worldheart for bridge-to-transplant study of the Levacor Ventricular Assist Device

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Newly discovered anti-aging gene linked to high blood pressure

Newly discovered anti-aging gene linked to high blood pressure

Medicare picks twelve New Jersey hospitals to test incentive system

Medicare picks twelve New Jersey hospitals to test incentive system

Bioheart's executive management team strengthened by the inclusion of board members

Bioheart's executive management team strengthened by the inclusion of board members

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.